CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Novo Nordisk Inc. recalls Wegovy (semaglutide) Injection

Read the official FDA notice

Published
7 Jan 2026
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Presence of Particulate Matter: Hair was found in a prefilled syringe

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4501-14

Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14

Brand / company
Novo Nordisk Inc.
Codes / lots
Lot #: RZFYK06, RZFYA53; Exp Date 3/31/2027 | Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026
Distribution
Nationwide within the United States.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 7 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.